Did not get sick with any other shots
Tirzepatide holds FDA approvals as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well
Some people space them by a few hours to aid absorption
As a result, only a very small percentage of patients in our practice require surgery to resolve their heel pain
[(accessed on 2 May 2025)];2024 Available online: 12.Ghirardi L., Pettersson E., Taylor M.J., Freitag C.M., Franke B., Asherson P., Larsson H., Kuja-Halkola R
Solutions: Extend trial to 6 months before concluding inefficacy (some benefits take longer), increase dosing within safe ranges if using lower end, switch peptides (try Cerebrolysin if using BPC-157, or vice versa), add comprehensive eye exam to rule out progression versus peptide failure, consider peptides preventing worsening rather than producing improvement, discontinue if truly no benefit after 6 months rigorous trial